Nabriva Therapeutics Plc (NBRV) Return on Investment ROI from the second quarter of 2023 to second quarter of 2022 and for the year 2023, average high and low, overall ranking from Jun 30 2023 to Jun 30 2022 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Nabriva Therapeutics Plc  (NASDAQ: NBRV)


Nabriva Therapeutics Plc's ROI from its second quarter of 2023 to the second quarter of 2022 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Nabriva Therapeutics Plc's ROI in the second quarter of 2023?
Nabriva Therapeutics Plc recorded a cumulative net loss of $-55 million during 12 months ending in the second quarter of 2023, resulting in a negative return on investment (ROI) of -1514.76%.

Within the Healthcare sector 1038 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2023 from 4264 to 5197.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter
Y / Y Investment Change TTM -93.18 % -75.17 % -56.22 % -31.15 % -4.77 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions -13 -4 5 27 36
Return On Investment (TTM) - - -196.86 % -111.46 % -87.47 %
NBRV's Overall Ranking # 5197 # 4264 # 4617 # 0 # 0
Seq. Investment Change TTM -76.93 % -45.76 % -31.79 % -20.08 % -16.01 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -55 -54 -57 -47 -47

NBRV Company Profile >> Back to NBRV Roi Comparisons >> See Annual NBRV Return On Investment



Return On Investment NBRV's Ranking
Within: No.
Industry # 506
Sector # 1039
Overall # 5197

Return On Investment Statistics
High Average Low
-74.53 %
-174.04 %
-1514.76 %
(Mar 31 2022)   (Jun 30 2023)







Financial Statements
Nabriva Therapeutics Plc's II. Quarter Investments $ -13 Millions NBRV's Balance sheet
Nabriva Therapeutics Plc's II. Quarter Income $ -12 Millions Quarterly NBRV's Income Statement
NBRV's Income by Division See NBRV's Income by Division


NBRV Annual Return On Investment (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2018)
2018
Total Investments in Millions 5 59 41 78 93
Y / Y Investment Growth -92.29 % 44.06 % -47.72 % -15.96 % 12.17 %
Net Income in Millions -57 -49 -69 -83 -115
Y / Y Net Income Growth - - - - -
Annual Return On Investment -1264.32 % -84.27 % -170.59 % -106.24 % -123.82 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
NBRV's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for NBRV's Competitors
Subscribers only: Roi for Nabriva Therapeutics Plc's Suppliers
Subscribers only: Return On Investment for NBRV's Customers

Other Ratios
NBRV's Roa NBRV's Inventory Turnover Ratio NBRV's Growth Rates NBRV's Dividend Statistics
NBRV's Profitability Ratios NBRV's Asset Turnover Ratio NBRV's Dividend Growth
NBRV's Roe NBRV's Valuation Ratios NBRV's Financial Strength Ratios NBRV's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2023, within Healthcare Sector ROI

Date modified: 2026-09-08T15:11:04+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.